News from the CCC

We are pleased to share that Robrina Walker, PhD, who joined Emmes in May 2021 as a Project Leader, now serves as the Co-PI of the CCC, alongside CCC PI Eve Jelstrom.

In addition to helping support and manage the CCC program/portfolio as a whole, Robrina’s direct study work includes being a Project Leader (the individual accountable for the CCC or DSC team’s support of a study) for CTN-0100 RDD (for both CCC & DSC), CTN-0121 Hi-SIRI (CCC & DSC), CTN-0102XR (CCC), and CTN-0144 (CCC).

Robrina brings to Emmes nearly 25 years’ experience in clinical research in substance use disorder treatment trials funded by the Veteran’s Administration, NIAAA, and NIDA, 15 years of which have included the NIDA CTN. From 2008 to 2021, Robrina was a key Co-Investigator of the Texas Node (rebranded the Big South/West Node in 2020) and was responsible for scientific contributions and oversight, building out the network of investigators and study sites, and administrative/budgetary oversight. Robrina served in various roles over the years, including QA Monitor, Site PI, protocol development team member, Lead Investigator Team member, and mentor/supervisor to trainees and new investigators. In her final years at the node, Robrina served as Co-Lead Investigator and National Project Director for the groundbreaking CTN-0068 ADAPT-2 trial.

Robrina is happy to add her experiences from the node side of the CTN to the support the CCC and DSC provides via the NIDA CCTN contracts.